Insider trades
Sushil Patel, Director of Revolution Medicines RVMD, has filed 0 purchases and 11 sales on the open market. Over the past 12 months that comes to a net sale of $300.9K. The latest trade was on 06/18.
Sushil Patel
Director
- Company
- Revolution Medicines RVMD
- First filing
- 23/04/04
- Trades
- 36 trades
- Buys / sales
- 0 / 11
- 12-month net buying
- −$300.9K
- Last trade
- 06/18
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Replimune GroupREPL | Open-market sale | 05/18 | 05/20 | 37,324 sh | $5.08 | $189,605.92 | −4.8% |
Replimune GroupREPL | Open-market sale10b5-1 plan | 25/12/02 | 25/12/04 | 10,000 sh | $11.13 | $111,300 | −2.9% |
Replimune GroupREPL | Open-market sale | 25/05/20 | 25/05/22 | 25,105 sh | $8.06 | $202,346.3 | −6.8% |
Replimune GroupREPL | Open-market sale10b5-1 plan | 24/12/16 | 24/12/18 | 10,000 sh | $12.42 | $124,200 | −4.7% |
| Open-market sale10b5-1 plan | 24/10/31 | 24/11/04 | 5,000 sh | $54.14 | $270,700 | −20.0% | |
| Open-market sale10b5-1 plan | 24/07/09 | 24/07/10 | 2,155 sh | $44.00 | $94,820 | −9.7% | |
Replimune GroupREPL | Open-market sale | 24/05/16 | 24/05/20 | 20,194 sh | $6.47 | $130,655.18 | −8.7% |
| Open-market sale10b5-1 plan | 24/04/10 | 24/04/12 | 2,155 sh | $37.00 | $79,735 | −12.1% | |
| Open-market sale10b5-1 plan | 23/06/13 | 23/06/15 | 5,698 sh2 trades | $24.04avg. | $137,008.27 | −3.7% | |
Replimune GroupREPL | Open-market sale | 23/05/16 | 23/05/18 | 15,575 sh | $18.05 | $281,128.75 | −9.2% |